• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.糖尿病腹膜透析患者血糖控制与腹膜、导管隧道及出口处感染发生率的相关性。
Perit Dial Int. 2014 Sep-Oct;34(6):618-26. doi: 10.3747/PDI.2012.00185. Epub 2013 Jul 1.
2
Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.居家记录腹膜透析导管出口处情况与腹膜透析相关感染发生率之间的关联
Int Urol Nephrol. 2018 Apr;50(4):763-769. doi: 10.1007/s11255-018-1789-x. Epub 2018 Jan 18.
3
Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.腹膜透析出口处敷料与感染:一项随机对照试验性研究
Perit Dial Int. 2016 Mar-Apr;36(2):135-9. doi: 10.3747/pdi.2014.00195. Epub 2015 Sep 15.
4
Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.外用洗必泰和莫匹罗星预防新发腹膜透析患者出口处感染的比较
Perit Dial Int. 2017 May-Jun;37(3):266-272. doi: 10.3747/pdi.2016.00257. Epub 2017 Feb 9.
5
Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.一种银质装置预防腹膜透析患者导管相关感染的效果:导管出口处银环预防研究
Am J Kidney Dis. 1998 Nov;32(5):752-60. doi: 10.1016/s0272-6386(98)70130-1.
6
Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.在低发病率环境中预防腹膜导管隧道和出口部位感染的目标识别
Perit Dial Int. 2016 Jan-Feb;36(1):43-51. doi: 10.3747/pdi.2014.00131. Epub 2014 Oct 7.
7
Are ISPD Guidelines on Peritonitis Diagnosis Too Narrow? A 15-Year Retrospective Single-Center Cohort Study on PD-Associated Peritonitis Accounting for Untrained Patients.ISPD 腹膜炎诊断指南是否过于狭隘?一项回顾性单中心队列研究,纳入 15 年 PD 相关性腹膜炎病例,涵盖未经培训患者。
Perit Dial Int. 2019 May-Jun;39(3):220-228. doi: 10.3747/pdi.2018.00179. Epub 2019 Mar 6.
8
Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?腹膜透析患者行血液透析前死亡是否有影响?
Nefrologia. 2012 May 14;32(3):335-42. doi: 10.3265/Nefrologia.pre2012.Jan.11143. Epub 2012 Apr 17.
9
Prevalence and risk factors of exit-site infection in incident peritoneal dialysis patients.新发腹膜透析患者出口处感染的患病率及危险因素
Perit Dial Int. 2020 Mar;40(2):164-170. doi: 10.1177/0896860819886965.
10
The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.蜜罐研究方案:一项关于在腹膜透析患者中应用Medihoney抗菌伤口凝胶进行出口部位护理以预防导管相关感染的随机对照试验。
Perit Dial Int. 2009 May-Jun;29(3):303-9.

引用本文的文献

1
The impact of icodextrin on the outcomes of incident peritoneal dialysis patients.聚蔗糖对新发腹膜透析患者结局的影响。
PLoS One. 2024 Mar 29;19(3):e0297688. doi: 10.1371/journal.pone.0297688. eCollection 2024.
2
Peritoneal Dialysis-Related Infections.腹膜透析相关性感染。
Clin J Am Soc Nephrol. 2024 May 1;19(5):641-649. doi: 10.2215/CJN.0000000000000280. Epub 2023 Aug 14.
3
The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis.糖尿病与高密度脂蛋白胆固醇水平低并存与腹膜透析相关腹膜炎之间的关联。
Diabetol Metab Syndr. 2022 Apr 29;14(1):60. doi: 10.1186/s13098-022-00832-x.
4
Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis.糖尿病对腹膜透析相关性腹膜炎发病的影响。
PLoS One. 2019 Dec 12;14(12):e0225316. doi: 10.1371/journal.pone.0225316. eCollection 2019.
5
Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.在低发病率环境中预防腹膜导管隧道和出口部位感染的目标识别
Perit Dial Int. 2016 Jan-Feb;36(1):43-51. doi: 10.3747/pdi.2014.00131. Epub 2014 Oct 7.

本文引用的文献

1
Prognostic factors for peritonitis outcome.腹膜炎预后的预测因素。
Contrib Nephrol. 2012;178:264-270. doi: 10.1159/000337889. Epub 2012 May 25.
2
Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study.良好的血糖控制与腹膜透析糖尿病患者的生存改善相关:一项前瞻性观察研究。
PLoS One. 2012;7(1):e30072. doi: 10.1371/journal.pone.0030072. Epub 2012 Jan 23.
3
Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis.非危重症住院患者的血糖控制:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2012 Jan;97(1):49-58. doi: 10.1210/jc.2011-2100. Epub 2011 Nov 16.
4
ISPD position statement on reducing the risks of peritoneal dialysis-related infections.国际腹膜透析学会关于降低腹膜透析相关感染风险的立场声明。
Perit Dial Int. 2011 Nov-Dec;31(6):614-30. doi: 10.3747/pdi.2011.00057. Epub 2011 Aug 31.
5
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients.巴西腹膜透析研究(BRAZPD)患者首次腹膜炎发作的地理和教育因素及风险。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1944-51. doi: 10.2215/CJN.11431210. Epub 2011 Jul 7.
6
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.糖尿病腹膜透析患者的血糖控制与生存。
Clin J Am Soc Nephrol. 2011 May;6(5):1041-8. doi: 10.2215/CJN.08921010. Epub 2011 Apr 21.
7
Peritoneal dialysis-related infections recommendations: 2010 update.腹膜透析相关感染的建议:2010年更新版
Perit Dial Int. 2010 Jul-Aug;30(4):393-423. doi: 10.3747/pdi.2010.00049.
8
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.非假单胞菌革兰氏阴性菌腹膜炎的预测因素、治疗和结局。
Kidney Int. 2010 Aug;78(4):408-14. doi: 10.1038/ki.2010.149. Epub 2010 May 26.
9
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases.澳大利亚腹膜透析患者凝固酶阴性葡萄球菌性腹膜炎:936 例患者的预测因素、治疗和结局。
Nephrol Dial Transplant. 2010 Oct;25(10):3386-92. doi: 10.1093/ndt/gfq222. Epub 2010 Apr 22.
10
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.澳大利亚腹膜透析患者的金黄色葡萄球菌性腹膜炎:503 例病例的预测因素、治疗和结局。
Perit Dial Int. 2010 May-Jun;30(3):311-9. doi: 10.3747/pdi.2008.00258. Epub 2010 Feb 26.

糖尿病腹膜透析患者血糖控制与腹膜、导管隧道及出口处感染发生率的相关性。

Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.

作者信息

Rodríguez-Carmona Ana, Pérez-Fontán Miguel, López-Muñiz Andrés, Ferreiro-Hermida Tamara, García-Falcón Teresa

机构信息

Division of Nephrology, University Hospital A Coruña, and Health Sciences Faculty, University of A Coruña, A Coruña, Spain.

出版信息

Perit Dial Int. 2014 Sep-Oct;34(6):618-26. doi: 10.3747/PDI.2012.00185. Epub 2013 Jul 1.

DOI:10.3747/PDI.2012.00185
PMID:23818005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4164406/
Abstract

BACKGROUND

Diabetes mellitus, especially if complicated by poor glycemic control, portends an increased risk of infection. The significance of this association in the case of diabetic patients undergoing peritoneal dialysis (PD) has not been assessed.

METHODS

Using a retrospective observational design, we analyzed the association between glycemic control at the start of PD (estimated from glycosylated hemoglobin levels) and the risk of peritoneal and catheter tunnel and exit-site infections during follow-up in 183 incident patients on PD. We used the median value of glycosylated hemoglobin to classify patients into good (group A) or poor (group B) glycemic control groups. We applied multivariate strategies of analysis to control for other potential predictors of PD-related infection.

RESULTS

Groups A and B differed significantly in age, dialysis vintage, use of insulin, and rate of Staphylococcus aureus carriage. Neither the incidence (0.60 episodes in group A vs 0.56 episodes in group B per patient-year) nor the time to a first peritoneal infection (median: 42 months vs 38 months) differed significantly between the study groups. In contrast, group B had a significantly higher incidence of catheter tunnel and exit-site infections (0.23 episodes vs 0.12 episodes per patient-year) and shorter time to a first infection episode (64 months vs 76 months, p = 0.004). The difference persisted in multivariate analysis (adjusted hazard ratio: 2.65; 95% confidence interval: 1.13 to 6.05; p = 0.013). We observed no differences between the study groups in the spectrum of causative organisms or in the outcomes of PD-related infections.

CONCLUSIONS

Poor glycemic control is a consistent predictor of subsequent risk of catheter tunnel and exit-site infection, but not of peritoneal infection, among diabetic patients starting PD therapy.

摘要

背景

糖尿病,尤其是合并血糖控制不佳时,预示着感染风险增加。这种关联在接受腹膜透析(PD)的糖尿病患者中的意义尚未得到评估。

方法

采用回顾性观察性设计,我们分析了183例新发PD患者在PD开始时的血糖控制情况(根据糖化血红蛋白水平估算)与随访期间腹膜、导管隧道及出口部位感染风险之间的关联。我们使用糖化血红蛋白的中位数将患者分为血糖控制良好(A组)或不佳(B组)两组。我们应用多变量分析策略来控制其他与PD相关感染的潜在预测因素。

结果

A组和B组在年龄、透析龄、胰岛素使用情况及金黄色葡萄球菌携带率方面存在显著差异。研究组之间的感染发生率(A组每位患者每年0.60次发作,B组每位患者每年0.56次发作)及首次腹膜感染时间(中位数:A组42个月,B组38个月)均无显著差异。相比之下,B组的导管隧道及出口部位感染发生率显著更高(每位患者每年0.23次发作 vs 0.12次发作),且首次感染发作时间更短(64个月 vs 76个月,p = 0.004)。在多变量分析中,这种差异仍然存在(调整后的风险比:2.65;95%置信区间:1.13至6.05;p = 0.013)。我们观察到研究组之间在致病微生物谱或PD相关感染的结局方面没有差异。

结论

在开始PD治疗的糖尿病患者中,血糖控制不佳是随后导管隧道及出口部位感染风险的一致预测因素,但不是腹膜感染的预测因素。